Mental Health DailyResearch. Evidence. Perspective.Published research on ADHD.
Adults with type 2 diabetes who also had ADHD died at a higher rate than those without ADHD in a 2026 study of 1.9 million adults newly diagnosed with diabetes across 7 countries. They did n…
Read articleGuanfacine, a non-stimulant ADHD medication, reduced hyperactivity in autistic children in a placebo-controlled trial. A 2026 review argues it may also steady prefrontal brain signaling and …
Read articleAmong broad child behavior questionnaires used to screen for ADHD, the short hyperactivity-inattention subscale of the Strengths and Difficulties Questionnaire (SDQ) has the strongest measur…
Read articleA 2026 meta-analysis of 50 studies estimated that about 1 in 3 people with neurofibromatosis type 1 (NF1) have ADHD (33%), and that roughly 1 in 10 have autism (11%), seizures (11%), depress…
Read articleA 2025 scoping review of 292 adult ADHD randomized controlled trials found that 49.7% allocated diagnosis without a general psychopathology assessment, and only 35% reported that psychiatris…
Read articleA 2026 medRxiv preprint using parent-cocreated sensory-related outcome measures found that 83% of children and teens improved on at least 1 PROMIS domain during 6 months of bumetanide treatm…
Read articleA 166-child resting-state fMRI study found that clinician-observed autism severity, not ADHD severity, tracked connectivity strength between a left middle frontal gyrus node and the posterio…
Read article
